Base Pair Biotechnologies Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.15M
- Investors
-
9
Base Pair Biotechnologies General Information
Description
Operator of a biotechnology platform intended to offer customized aptamer discovery and development services. The company's platform includes novel libraries, patented and trade secret methods for multiplexing the aptamer discovery process, and highly effective screening and validation methods, enabling clients in multiple market segments to receive diagnostics, animal testing, therapeutics, agriculture, and environmental testing services.
Contact Information
Website
www.basepairbio.comCorporate Office
- 8619 Broadway Street
- Suite 100
- Pearland, TX 77584
- United States
Corporate Office
- 8619 Broadway Street
- Suite 100
- Pearland, TX 77584
- United States
Base Pair Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 11-Aug-2023 | $2.15M | Completed | Generating Revenue | ||
| 8. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 28-Apr-2020 | Completed | Generating Revenue | |||
| 6. Grant | 01-Mar-2019 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A3) | 28-Nov-2017 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 29-Apr-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 16-Sep-2013 | $500K | $1000K | Completed | Startup | |
| 1. Early Stage VC (Series A) | 19-Aug-2013 | $500K | $500K | Completed | Startup |
Base Pair Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 295,858 | $0.001000 | $1.69 | $1.69 | 1x | $1.69 | 4.85% | |
| Series A | 344,500 | $0.001000 | $1.45 | $1.45 | 1x | $1.45 | 5.65% |
Base Pair Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Base Pair Biotechnologies Patents
Base Pair Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220396795-A1 | Functional ligands to sars-cov-2 spike protein | Pending | 12-May-2020 | ||
| CA-3178640-A1 | Functional ligands to sars-cov-2 spike protein | Pending | 12-May-2020 | ||
| US-20210041470-A1 | Functional ligands to opioids and opioid metabolites | Inactive | 27-Mar-2019 | ||
| US-11608356-B1 | Functional ligands to colistin | Active | 22-Feb-2019 | ||
| EP-3787406-A1 | Functional ligands to dicamba | Inactive | 03-May-2018 | C12N15/115 |
Base Pair Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Base Pair Biotechnologies Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Government | |||
| National Cancer Institute | Government | |||
| National Institute for Allergy and Infectious Disease | Government | |||
| National Institute on Drug Abuse (NIDA) | Government | |||
| United States Centers for Disease Control and Prevention | Government |
Base Pair Biotechnologies FAQs
-
When was Base Pair Biotechnologies founded?
Base Pair Biotechnologies was founded in 2012.
-
Where is Base Pair Biotechnologies headquartered?
Base Pair Biotechnologies is headquartered in Pearland, TX.
-
What is the size of Base Pair Biotechnologies?
Base Pair Biotechnologies has 11 total employees.
-
What industry is Base Pair Biotechnologies in?
Base Pair Biotechnologies’s primary industry is Biotechnology.
-
Is Base Pair Biotechnologies a private or public company?
Base Pair Biotechnologies is a Private company.
-
What is Base Pair Biotechnologies’s current revenue?
The current revenue for Base Pair Biotechnologies is .
-
How much funding has Base Pair Biotechnologies raised over time?
Base Pair Biotechnologies has raised $5.42M.
-
Who are Base Pair Biotechnologies’s investors?
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, National Institute for Allergy and Infectious Disease, National Institute on Drug Abuse (NIDA), and United States Centers for Disease Control and Prevention are 5 of 9 investors who have invested in Base Pair Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
